Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer
Journal of Cancer Research & Clinical Oncology, 06/25/2012
Clinical Article
Du Y et al. – The present study’s results suggest that detecting Nanog might be helpful for diagnosing esophageal squamous cell carcinoma (ESCC), and Nanog siRNA combined with Cisplatin may be a feasible strategy to enhance the sensitivity of chemotherapy in patients with ESCC.



